ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
期權訓練營
投資學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
獎項與榮譽
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
因塞特醫療
130.42
+2.44
1.90%
成交量：
59.61萬
成交額：
7,748.45萬
市值：
264.35億
市盈率：
16.61
高：
130.69
開：
128.19
低：
127.50
收：
127.98
52周最高：
132.60
52周最低：
81.09
股本：
2.03億
流通股本：
1.70億
量比：
0.72
換手率：
0.35%
股息：
- -
股息率：
- -
每股收益(TTM):
7.85
每股收益(LYR):
6.41
淨資產收益率：
30.67%
總資產收益率：
16.83%
市淨率：
4.17
市盈率(LYR):
20.35
資料載入中...
總覽
公司
新聞資訊
公告
因塞特醫療：關鍵Frontmind試驗顯示Tafasitamab聯合療法顯著延長無進展生存期
美股速递
·
05/30
Incyte的血液癌症聯合用藥方案可降低疾病進展風險，但副作用發生率較高
路透中文
·
05/30
數據簡報-製藥行業加大力度佈局人工智能，寄望於大幅削減成本並縮短研發周期
路透中文
·
05/20
美國研究綜述-CAVA集團、Eagle Materials、Vertiv控股
路透中文
·
05/20
美國研究綜述-CAVA集團、Eagle Materials、Vertiv控股
路透中文
·
05/20
因塞特醫療與愛迪生科學宣佈戰略合作，將啓用Kosmos AI平台賦能研發
美股速递
·
05/19
因塞特醫療宣佈超過20篇摘要獲選於2026年歐洲血液學協會大會展示
美股速递
·
05/12
因塞特醫療Opzelura耐受性良好：24周內僅1.7%用藥部位反應且無新增安全信號
美股速递
·
05/07
因塞特公布Opzelura乳膏治療中重度特應性皮炎三期試驗24周長期數據
美股速递
·
05/07
因塞特醫療：蘆可替尼乳膏歐盟II類變更申請獲數據支持，反饋預期2026年上半年
美股速递
·
05/07
因塞特醫療宣佈FDA批准Jakafi XR™緩釋片用於治療骨髓纖維化、真性紅細胞增多症及移植物抗宿主病
美股速递
·
05/02
因賽特受抗癌藥需求強勁推動，第一季度業績超預期
路透中文
·
04/28
因塞特醫療Jakafi XR新藥即將迎來關鍵節點 美國監管決定與中期商業上市計劃浮出水面
美股速递
·
04/28
財報前瞻｜因塞特醫療本季度營收預計按年增22.99%，機構多持積極態度
财报Agent
·
04/20
背景資料-醫藥行業加倍重視人工智能，希望能降低成本、縮短時間
路透中文
·
04/14
Adagene與Incyte達成臨床合作，評估Muzastotug (Adg126)聯合Incyte的TgfßR2xPD-1雙特異性抗體(Inca33890)用於微衞星穩定結直腸癌(MSS CRC)患者
美股速递
·
04/02
人工智能引領的合同研究公司拋售可能是對顛覆性風險的誤判
路透中文
·
03/31
因塞特醫療在2026年美國皮膚病學會年會公布Povorcitinib治療化膿性汗腺炎54周積極最新數據
美股速递
·
03/29
Incyte 的皮膚病藥物在後期試驗中顯示出長期症狀緩解效果
路透中文
·
03/29
因塞特醫療：截至第54周，STOP-HS1與STOP-HS2研究中所有組別均觀察到臨床持久緩解，高達71.4%患者達到HISCR50
美股速递
·
03/29
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrdive.com/hant/stock/INCY/news?page=3"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"INCY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"INCY\",,,,,undefined,":{"symbol":"INCY","market":"US","secType":"STK","nameCN":"因塞特醫療","latestPrice":130.415,"timestamp":1787680351251,"preClose":127.98,"halted":0,"volume":596050,"delay":0,"changeRate":0.019026410376621252,"floatShares":169819727,"shares":202697746,"eps":7.85,"marketStatus":"交易中","change":2.435,"latestTime":"08-25 13:52:37 EDT","open":128.19,"high":130.6873,"low":127.5,"amount":77484533.035,"amplitude":0.024905,"askPrice":130.46,"askSize":28,"bidPrice":130.41,"bidSize":10,"shortable":3,"etf":0,"ttmEps":7.85,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1787688000000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":127.98,"preHourTrading":{"tag":"盘前","latestPrice":128.38,"preClose":127.98,"latestTime":"09:29 EDT","volume":2384,"amount":306210.54368,"timestamp":1787664599999,"change":0.4,"changeRate":0.003125,"amplitude":0.04532},"postHourTrading":{"tag":"盘后","latestPrice":129.95,"preClose":127.98,"latestTime":"19:55 EDT","volume":67514,"amount":8639814.7099,"timestamp":1787615748206,"change":1.97,"changeRate":0.015393,"amplitude":0.015393},"volumeRatio":0.718056,"impliedVol":0.3308,"impliedVolPercentile":0.2112},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"INCY\",,,,,undefined,":{"symbol":"INCY","floatShares":169819727,"roa":"16.83%","roe":"30.67%","lyrEps":6.41,"volumeRatio":0.718056,"shares":202697746,"dividePrice":0,"high":130.6873,"amplitude":0.024905,"preClose":127.98,"low":127.5,"week52Low":81.09,"pbRate":"4.17","psRate":"4.54","week52High":132.6,"institutionHeld":0.9185,"latestPrice":130.415,"committee":-0.473684,"eps":7.85,"divideRate":0,"volume":596050,"delay":0,"ttmEps":7.85,"open":128.19,"prevYearClose":98.77,"prevWeekClose":127.81,"prevMonthClose":119.52,"prevQuarterClose":113.36,"fiveDayClose":123.47,"twentyDayClose":129.93,"sixtyDayClose":96.74},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/INCY\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-07-28","symbol":"INCY","fiscalQuarterEnding":"2026/06","expectedEps":1.76,"name":null,"time":"盤前","type":"earning","dateTimestamp":1785211200000,"reportTimeType":"pre","actualEps":2.8},{"market":"US","date":"2026-04-28","symbol":"INCY","fiscalQuarterEnding":"2026/03","expectedEps":1.14,"name":null,"time":"盤前","type":"earning","dateTimestamp":1777348800000,"reportTimeType":"pre","actualEps":1.55},{"market":"US","date":"2026-02-10","symbol":"INCY","fiscalQuarterEnding":"2025/12","expectedEps":1.64,"name":null,"time":"盤前","type":"earning","dateTimestamp":1770699600000,"reportTimeType":"pre","actualEps":1.09},{"market":"US","date":"2025-10-28","symbol":"INCY","fiscalQuarterEnding":"2025/09","expectedEps":1.38,"name":null,"time":"盤前","type":"earning","dateTimestamp":1761624000000,"reportTimeType":"pre","actualEps":2.03},{"market":"US","date":"2025-07-29","symbol":"INCY","fiscalQuarterEnding":"2025/06","expectedEps":1.14,"name":null,"time":"盤前","type":"earning","dateTimestamp":1753761600000,"reportTimeType":"pre","actualEps":1.31}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"INCY\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"INCY\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2069,"buy":0.2414,"hold":0.5517,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.2414,"analysts":29,"updateTime":1787457600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/INCY\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"INCY","date":"2026-08-21","current":16.303185,"percent":0.124796,"low":12.870654,"twenty":16.887518,"median":22.74195,"eighty":53.112386,"high":648.145308,"avg":97.761667,"sd":164.540207,"marketCap":25787207246},"quantilePoints":[{"date":"2021-08-27","current":49.499207,"twenty":-126.920152,"median":-53.75838,"eighty":133.981527,"marketCap":16712813157},{"date":"2021-09-03","current":49.767371,"twenty":-126.920152,"median":-53.75838,"eighty":132.851508,"marketCap":16803355618},{"date":"2021-09-10","current":46.516696,"twenty":-126.920152,"median":-53.75838,"eighty":131.356968,"marketCap":15705804331},{"date":"2021-09-17","current":49.701965,"twenty":-126.920152,"median":-53.75838,"eighty":73.50992,"marketCap":16781272091},{"date":"2021-09-24","current":45.130091,"twenty":-126.920152,"median":-53.75838,"eighty":72.160274,"marketCap":15237633561},{"date":"2021-10-01","current":44.613384,"twenty":-126.920152,"median":-53.75838,"eighty":71.599051,"marketCap":15063173698},{"date":"2021-10-08","current":43.095966,"twenty":-126.920152,"median":-53.75838,"eighty":70.390135,"marketCap":14550835874},{"date":"2021-10-15","current":42.880127,"twenty":-126.920152,"median":-53.75838,"eighty":69.308384,"marketCap":14477960235},{"date":"2021-10-22","current":43.03056,"twenty":-126.920152,"median":-53.75838,"eighty":68.891282,"marketCap":14528752347},{"date":"2021-10-29","current":43.808891,"twenty":-126.920152,"median":-53.75838,"eighty":68.326669,"marketCap":14791546317},{"date":"2021-11-05","current":28.040026,"twenty":-126.321891,"median":-53.279085,"eighty":68.258847,"marketCap":14989637337},{"date":"2021-11-12","current":27.110317,"twenty":-125.553074,"median":-52.997601,"eighty":68.258847,"marketCap":14492633446},{"date":"2021-11-19","current":26.655793,"twenty":-125.039639,"median":-47.426815,"eighty":68.258847,"marketCap":14249653767},{"date":"2021-11-26","current":28.254893,"twenty":-123.924854,"median":-46.283755,"eighty":68.258847,"marketCap":15104500458},{"date":"2021-12-03","current":27.180562,"twenty":-122.424514,"median":-43.300979,"eighty":68.258847,"marketCap":14530184852},{"date":"2021-12-10","current":27.023544,"twenty":-120.541483,"median":-41.894137,"eighty":68.258847,"marketCap":14446246417},{"date":"2021-12-17","current":30.118443,"twenty":-119.13698,"median":26.841735,"eighty":68.258847,"marketCap":16100717146},{"date":"2021-12-23","current":30.358101,"twenty":-115.775745,"median":26.911979,"eighty":68.258847,"marketCap":16228833704},{"date":"2021-12-31","current":30.329177,"twenty":-112.581547,"median":27.15577,"eighty":68.258847,"marketCap":16213371361},{"date":"2022-01-07","current":30.242404,"twenty":-111.158033,"median":27.511125,"eighty":68.252065,"marketCap":16166984331},{"date":"2022-01-14","current":30.940719,"twenty":-109.706662,"median":27.854084,"eighty":68.252065,"marketCap":16540289475},{"date":"2022-01-21","current":30.90353,"twenty":-109.122909,"median":28.14746,"eighty":68.252065,"marketCap":16520409320},{"date":"2022-01-28","current":30.672136,"twenty":-107.744794,"median":29.62673,"eighty":68.252065,"marketCap":16396710574},{"date":"2022-02-04","current":30.035802,"twenty":-106.666568,"median":30.077123,"eighty":68.252065,"marketCap":16056539022},{"date":"2022-02-11","current":15.576603,"twenty":-105.677621,"median":30.151499,"eighty":68.252065,"marketCap":14775669617},{"date":"2022-02-18","current":15.989584,"twenty":-103.869131,"median":30.151499,"eighty":68.252065,"marketCap":15167415202},{"date":"2022-02-25","current":15.963918,"twenty":-103.539483,"median":30.151499,"eighty":68.252065,"marketCap":15143069431},{"date":"2022-03-04","current":16.344234,"twenty":-102.763434,"median":30.151499,"eighty":68.252065,"marketCap":15503829489},{"date":"2022-03-11","current":17.251858,"twenty":-101.447128,"median":30.151499,"eighty":68.252065,"marketCap":16364784474},{"date":"2022-03-18","current":17.545844,"twenty":-100.506256,"median":30.151499,"eighty":68.252065,"marketCap":16643654212},{"date":"2022-03-25","current":18.306475,"twenty":-99.373088,"median":30.151499,"eighty":68.252065,"marketCap":17365174328},{"date":"2022-04-01","current":18.651792,"twenty":-97.445558,"median":30.151499,"eighty":68.252065,"marketCap":17692735608},{"date":"2022-04-08","current":19.407757,"twenty":-93.439406,"median":30.151499,"eighty":68.252065,"marketCap":18409829221},{"date":"2022-04-14","current":19.071772,"twenty":-91.423658,"median":30.151499,"eighty":68.252065,"marketCap":18091120948},{"date":"2022-04-22","current":17.867829,"twenty":-89.542294,"median":30.151499,"eighty":68.252065,"marketCap":16949082973},{"date":"2022-04-29","current":17.489847,"twenty":-88.994619,"median":30.151499,"eighty":68.252065,"marketCap":16590536167},{"date":"2022-05-06","current":17.838131,"twenty":-88.883056,"median":30.023406,"eighty":68.021473,"marketCap":16643654212},{"date":"2022-05-13","current":17.781404,"twenty":-88.883056,"median":29.345751,"eighty":67.499248,"marketCap":16590725323},{"date":"2022-05-20","current":17.776656,"twenty":-88.883056,"median":28.029696,"eighty":66.763386,"marketCap":16586295223},{"date":"2022-05-27","current":18.325054,"twenty":-88.883056,"median":27.587568,"eighty":65.832537,"marketCap":17097971799},{"date":"2022-06-03","current":17.558246,"twenty":-88.883056,"median":27.482201,"eighty":65.113631,"marketCap":16382510613},{"date":"2022-06-10","current":16.713095,"twenty":-88.883056,"median":27.06693,"eighty":64.292991,"marketCap":15593952774},{"date":"2022-06-17","current":16.919635,"twenty":-88.883056,"median":26.885121,"eighty":60.086945,"marketCap":15786662133},{"date":"2022-06-24","current":18.562456,"twenty":-88.883056,"median":26.36655,"eighty":58.867713,"marketCap":17319476810},{"date":"2022-07-01","current":18.439007,"twenty":-88.883056,"median":19.147526,"eighty":58.036609,"marketCap":17204294204},{"date":"2022-07-08","current":19.106106,"twenty":-88.883056,"median":19.102104,"eighty":57.517697,"marketCap":17826723285},{"date":"2022-07-15","current":18.999276,"twenty":-88.883056,"median":18.925681,"eighty":56.936909,"marketCap":17727046030},{"date":"2022-07-22","current":19.205815,"twenty":-88.883056,"median":18.904315,"eighty":56.208463,"marketCap":17919755389},{"date":"2022-07-29","current":18.441381,"twenty":-88.883056,"median":18.878115,"eighty":55.366109,"marketCap":17206509254},{"date":"2022-08-05","current":16.913825,"twenty":-88.883056,"median":18.721515,"eighty":55.122825,"marketCap":15983801593},{"date":"2022-08-12","current":17.415237,"twenty":-88.883056,"median":18.588795,"eighty":54.717821,"marketCap":16457642683},{"date":"2022-08-19","current":17.544692,"twenty":-88.883056,"median":18.439007,"eighty":54.475943,"marketCap":16579979532},{"date":"2022-08-26","current":16.824451,"twenty":-88.883056,"median":18.331526,"eighty":53.5014,"marketCap":15899341789},{"date":"2022-09-02","current":16.525528,"twenty":-88.883056,"median":18.243478,"eighty":52.597171,"marketCap":15616854883},{"date":"2022-09-09","current":16.99392,"twenty":-88.883056,"median":18.047294,"eighty":52.079665,"marketCap":16059491847},{"date":"2022-09-16","current":16.200713,"twenty":-88.883056,"median":17.954707,"eighty":50.829148,"marketCap":15309900607},{"date":"2022-09-23","current":15.74409,"twenty":-88.883056,"median":17.867829,"eighty":50.44787,"marketCap":14878385175},{"date":"2022-09-30","current":15.685246,"twenty":-88.883056,"median":17.800396,"eighty":50.239968,"marketCap":14822777516},{"date":"2022-10-07","current":16.10421,"twenty":-88.883056,"median":17.744168,"eighty":50.010331,"marketCap":15218704046},{"date":"2022-10-14","current":16.264264,"twenty":-88.883056,"median":17.643549,"eighty":49.808517,"marketCap":15369956878},{"date":"2022-10-21","current":16.612615,"twenty":-88.883056,"median":17.544692,"eighty":49.590775,"marketCap":15699154218},{"date":"2022-10-28","current":17.558814,"twenty":-88.883056,"median":17.448189,"eighty":49.403714,"marketCap":16593325371},{"date":"2022-11-04","current":19.630562,"twenty":-88.883056,"median":17.448189,"eighty":49.110861,"marketCap":17197353676},{"date":"2022-11-11","current":19.688971,"twenty":-88.883056,"median":17.448189,"eighty":48.910553,"marketCap":17248523034},{"date":"2022-11-18","current":19.668655,"twenty":-88.883056,"median":17.448189,"eighty":48.59263,"marketCap":17230724996},{"date":"2022-11-25","current":19.874357,"twenty":-88.883056,"median":17.448189,"eighty":48.454449,"marketCap":17410930125},{"date":"2022-12-02","current":21.111107,"twenty":-88.883056,"median":17.448189,"eighty":48.041963,"marketCap":18494385654},{"date":"2022-12-09","current":20.910485,"twenty":-88.883056,"median":17.448189,"eighty":47.59851,"marketCap":18318630035},{"date":"2022-12-16","current":20.831759,"twenty":-88.883056,"median":17.448189,"eighty":47.263641,"marketCap":18249662640},{"date":"2022-12-23","current":20.661611,"twenty":-88.883056,"median":17.448189,"eighty":47.016101,"marketCap":18100604076},{"date":"2022-12-30","current":20.3975,"twenty":-88.883056,"median":17.448189,"eighty":46.554796,"marketCap":17869229589},{"date":"2023-01-06","current":20.537174,"twenty":-88.211139,"median":17.541628,"eighty":46.554796,"marketCap":17991591097},{"date":"2023-01-13","current":20.527016,"twenty":-87.440338,"median":17.558814,"eighty":46.554796,"marketCap":17982692078},{"date":"2023-01-20","current":21.128884,"twenty":-86.920554,"median":17.688817,"eighty":46.554796,"marketCap":18509958937},{"date":"2023-01-27","current":21.763766,"twenty":-86.375415,"median":17.776656,"eighty":46.554796,"marketCap":19066147607},{"date":"2023-02-03","current":21.233005,"twenty":-85.224284,"median":17.831258,"eighty":46.554796,"marketCap":18601173879},{"date":"2023-02-10","current":51.876379,"twenty":-84.628433,"median":17.926219,"eighty":47.016101,"marketCap":17672207326},{"date":"2023-02-17","current":51.706207,"twenty":-84.430663,"median":18.016432,"eighty":47.263641,"marketCap":17614236422},{"date":"2023-02-24","current":50.410279,"twenty":-84.430663,"median":18.075782,"eighty":47.465954,"marketCap":17172765686},{"date":"2023-03-03","current":50.763714,"twenty":-84.430663,"median":18.306475,"eighty":47.986899,"marketCap":17293166796},{"date":"2023-03-10","current":47.131189,"twenty":-84.430663,"median":18.365412,"eighty":48.204376,"marketCap":16055710946},{"date":"2023-03-17","current":48.184949,"twenty":-84.430663,"median":18.530464,"eighty":48.335268,"marketCap":16414684625},{"date":"2023-03-24","current":45.966163,"twenty":-84.430663,"median":18.651792,"eighty":48.401919,"marketCap":15658833214},{"date":"2023-03-31","current":47.301362,"twenty":-84.412914,"median":18.778445,"eighty":48.397883,"marketCap":16113681850},{"date":"2023-04-06","current":48.28967,"twenty":-84.412914,"median":18.882782,"eighty":48.397883,"marketCap":16450359028},{"date":"2023-04-14","current":49.304159,"twenty":-84.430663,"median":19.071772,"eighty":48.454449,"marketCap":16795954805},{"date":"2023-04-21","current":48.335486,"twenty":-84.430663,"median":19.139343,"eighty":48.50111,"marketCap":16465966579},{"date":"2023-04-28","current":48.204584,"twenty":-84.430663,"median":19.205815,"eighty":48.553797,"marketCap":16421373575},{"date":"2023-05-05","current":45.522611,"twenty":-84.430663,"median":19.457874,"eighty":48.598963,"marketCap":14766214974},{"date":"2023-05-12","current":44.133343,"twenty":-84.430663,"median":19.577232,"eighty":48.598963,"marketCap":14315576596},{"date":"2023-05-19","current":43.761954,"twenty":-65.975243,"median":19.668655,"eighty":48.598963,"marketCap":14195108910},{"date":"2023-05-26","current":43.239259,"twenty":-63.609535,"median":19.757538,"eighty":48.598963,"marketCap":14025561798},{"date":"2023-06-02","current":42.30391,"twenty":-63.241519,"median":19.876896,"eighty":48.598963,"marketCap":13722161702},{"date":"2023-06-09","current":42.30391,"twenty":-62.97873,"median":20.184179,"eighty":48.598963,"marketCap":13722161702},{"date":"2023-06-16","current":43.03981,"twenty":-62.654259,"median":20.2337,"eighty":48.609617,"marketCap":13960866189},{"date":"2023-06-23","current":42.579013,"twenty":-62.203628,"median":20.44829,"eighty":48.620272,"marketCap":13811397024},{"date":"2023-06-30","current":42.537748,"twenty":-61.715907,"median":20.562569,"eighty":48.630926,"marketCap":13798011726},{"date":"2023-07-07","current":43.232382,"twenty":-61.507591,"median":20.746685,"eighty":48.630926,"marketCap":14023330915},{"date":"2023-07-14","current":42.599646,"twenty":-61.285022,"median":20.93842,"eighty":48.630926,"marketCap":13818089673},{"date":"2023-07-21","current":44.023302,"twenty":-60.953261,"median":21.128884,"eighty":48.639436,"marketCap":14279882467},{"date":"2023-07-28","current":43.108586,"twenty":-60.731546,"median":21.301572,"eighty":48.639436,"marketCap":13983175020},{"date":"2023-08-04","current":39.731882,"twenty":-60.438616,"median":21.456483,"eighty":48.639436,"marketCap":14561218421},{"date":"2023-08-11","current":40.05595,"twenty":-60.194533,"median":21.842492,"eighty":48.639436,"marketCap":14679984899},{"date":"2023-08-18","current":39.261068,"twenty":-59.937514,"median":26.841735,"eighty":48.639436,"marketCap":14388670895},{"date":"2023-08-25","current":39.273297,"twenty":-59.653506,"median":26.936772,"eighty":48.639436,"marketCap":14393152649},{"date":"2023-09-01","current":39.456731,"twenty":-59.512326,"median":27.180562,"eighty":48.639436,"marketCap":14460378958},{"date":"2023-09-08","current":38.796367,"twenty":-59.369499,"median":27.531785,"eighty":48.639436,"marketCap":14218364247},{"date":"2023-09-15","current":38.814711,"twenty":-59.210021,"median":27.887141,"eighty":48.639436,"marketCap":14225086878},{"date":"2023-09-22","current":35.959249,"twenty":-58.96037,"median":28.341665,"eighty":48.639436,"marketCap":13178597342},{"date":"2023-09-29","current":35.83696,"twenty":-58.783922,"median":29.746559,"eighty":48.639436,"marketCap":13133779803},{"date":"2023-10-06","current":35.959249,"twenty":-58.648658,"median":30.184555,"eighty":48.639436,"marketCap":13178597342},{"date":"2023-10-13","current":34.589606,"twenty":-58.325093,"median":30.329177,"eighty":48.639436,"marketCap":12676640906},{"date":"2023-10-20","current":34.020959,"twenty":-58.123791,"median":30.432478,"eighty":48.639436,"marketCap":12468239349},{"date":"2023-10-23","current":33.709121,"twenty":-58.104138,"median":30.444874,"eighty":48.639436,"marketCap":12353954625},{"date":"2023-11-03","current":28.460509,"twenty":-57.44054,"median":30.568835,"eighty":48.673477,"marketCap":12095175574},{"date":"2023-11-10","current":27.695867,"twenty":-57.041687,"median":30.568835,"eighty":48.673477,"marketCap":11770217179},{"date":"2023-11-17","current":28.471056,"twenty":-56.859827,"median":30.568835,"eighty":48.673477,"marketCap":12099657759},{"date":"2023-11-24","current":28.339221,"twenty":-56.671737,"median":30.568835,"eighty":48.673477,"marketCap":12043630450},{"date":"2023-12-01","current":28.655625,"twenty":-56.44742,"median":30.568835,"eighty":48.673477,"marketCap":12178095992},{"date":"2023-12-08","current":29.09859,"twenty":-55.919657,"median":30.566769,"eighty":48.664967,"marketCap":12366347752},{"date":"2023-12-15","current":33.665349,"twenty":-55.635877,"median":30.642536,"eighty":48.664967,"marketCap":14307133753},{"date":"2023-12-22","current":32.531569,"twenty":-55.314549,"median":30.804361,"eighty":48.664967,"marketCap":13825298892},{"date":"2023-12-29","current":33.080002,"twenty":-54.86823,"median":30.90353,"eighty":48.673477,"marketCap":14058372499},{"date":"2024-01-05","current":35.115533,"twenty":-54.444299,"median":31.099803,"eighty":48.675257,"marketCap":14923434158},{"date":"2024-01-12","current":33.280391,"twenty":-54.278027,"median":32.355824,"eighty":48.675257,"marketCap":14143534010},{"date":"2024-01-19","current":32.262626,"twenty":-54.097036,"median":32.479514,"eighty":48.677037,"marketCap":13711003180},{"date":"2024-01-26","current":32.125518,"twenty":-53.861692,"median":32.505541,"eighty":48.675257,"marketCap":13652734778},{"date":"2024-02-02","current":31.197401,"twenty":-53.506891,"median":32.505541,"eighty":48.675257,"marketCap":13258302520},{"date":"2024-02-09","current":30.24819,"twenty":-53.144235,"median":32.505541,"eighty":48.675257,"marketCap":12854905891},{"date":"2024-02-16","current":22.155837,"twenty":-52.564683,"median":32.440893,"eighty":48.588308,"marketCap":13240305768},{"date":"2024-02-23","current":22.884721,"twenty":-52.564683,"median":32.304813,"eighty":48.499532,"marketCap":13675886456},{"date":"2024-03-01","current":21.926651,"twenty":-52.492457,"median":32.083331,"eighty":48.414027,"marketCap":13103344830},{"date":"2024-03-08","current":22.178379,"twenty":-52.492457,"median":31.44525,"eighty":48.309305,"marketCap":13253777335},{"date":"2024-03-15","current":21.99428,"twenty":-52.492457,"median":30.994435,"eighty":48.204584,"marketCap":13143759533},{"date":"2024-03-22","current":21.686194,"twenty":-52.492457,"median":30.891134,"eighty":48.099863,"marketCap":12959648108},{"date":"2024-03-28","current":21.460766,"twenty":-52.492457,"median":30.738249,"eighty":47.955422,"marketCap":12824932431},{"date":"2024-04-05","current":20.660496,"twenty":-52.564683,"median":30.61994,"eighty":47.58148,"marketCap":12346691778},{"date":"2024-04-12","current":20.634196,"twenty":-52.564683,"median":30.4676,"eighty":47.410327,"marketCap":12330974949},{"date":"2024-04-19","current":19.845197,"twenty":-52.564683,"median":30.368431,"eighty":47.294817,"marketCap":11859470080},{"date":"2024-04-26","current":19.229027,"twenty":-52.492457,"median":30.308517,"eighty":47.22407,"marketCap":11491247231},{"date":"2024-05-03","current":15.991635,"twenty":-52.492457,"median":30.184555,"eighty":46.833129,"marketCap":11920868470},{"date":"2024-05-10","current":16.115134,"twenty":-52.492457,"median":29.750691,"eighty":46.53527,"marketCap":12012930178},{"date":"2024-05-17","current":17.127225,"twenty":-52.492457,"median":29.110225,"eighty":46.400692,"marketCap":12767387101},{"date":"2024-05-24","current":17.329127,"twenty":-52.492457,"median":28.924568,"eighty":45.817215,"marketCap":12917894069},{"date":"2024-05-31","current":17.283882,"twenty":-52.492457,"median":28.845467,"eighty":45.631052,"marketCap":12884165886},{"date":"2024-06-07","current":17.6187,"twenty":-52.492457,"median":28.618711,"eighty":45.300146,"marketCap":13133754440},{"date":"2024-06-14","current":18.909713,"twenty":-52.564683,"median":28.448595,"eighty":45.014977,"marketCap":14096131927},{"date":"2024-06-21","current":18.810172,"twenty":-52.636909,"median":28.254893,"eighty":44.814222,"marketCap":14021929925},{"date":"2024-06-28","current":18.505517,"twenty":-52.853586,"median":28.029696,"eighty":44.545997,"marketCap":13794826826},{"date":"2024-07-05","current":17.392472,"twenty":-52.853586,"median":27.883789,"eighty":44.45557,"marketCap":12965113525},{"date":"2024-07-12","current":18.789057,"twenty":-52.853586,"median":27.625789,"eighty":44.208996,"marketCap":14006190106},{"date":"2024-07-15","current":19.202302,"twenty":-52.853586,"median":27.587568,"eighty":44.133343,"marketCap":14314240843},{"date":"2024-08-02","current":127.521095,"twenty":-53.175656,"median":27.465673,"eighty":43.695796,"marketCap":12407164899},{"date":"2024-08-09","current":122.295145,"twenty":-53.175656,"median":27.465673,"eighty":43.695796,"marketCap":11898706108},{"date":"2024-08-16","current":122.097192,"twenty":-53.175656,"median":27.465673,"eighty":43.695796,"marketCap":11879446305},{"date":"2024-08-23","current":124.749758,"twenty":-53.175656,"median":27.465673,"eighty":43.695796,"marketCap":12137527661},{"date":"2024-08-30","current":130.470589,"twenty":-53.175656,"median":27.465673,"eighty":43.695796,"marketCap":12694135959},{"date":"2024-09-06","current":124.630986,"twenty":-53.175656,"median":27.465673,"eighty":43.695796,"marketCap":12125971779},{"date":"2024-09-13","current":125.422797,"twenty":-53.175656,"median":27.465673,"eighty":43.695796,"marketCap":12203010990},{"date":"2024-09-20","current":132.271958,"twenty":-53.175656,"median":27.465673,"eighty":43.695796,"marketCap":12869400164},{"date":"2024-09-27","current":128.926558,"twenty":-53.175656,"median":27.465673,"eighty":43.695796,"marketCap":12543909498},{"date":"2024-10-04","current":132.707454,"twenty":-53.175656,"median":27.465673,"eighty":43.695796,"marketCap":12911771730},{"date":"2024-10-11","current":129.401645,"twenty":-53.175656,"median":27.465673,"eighty":43.695796,"marketCap":12590133024},{"date":"2024-10-18","current":131.499943,"twenty":-53.175656,"median":27.465673,"eighty":43.695796,"marketCap":12794286933},{"date":"2024-10-25","current":129.144306,"twenty":-53.175656,"median":27.465673,"eighty":43.695796,"marketCap":12565095281},{"date":"2024-10-31","current":438.477708,"twenty":-53.175656,"median":27.465673,"eighty":43.695796,"marketCap":14242632908},{"date":"2024-11-08","current":488.35729,"twenty":-53.191367,"median":27.323117,"eighty":43.655773,"marketCap":15862821502},{"date":"2024-11-15","current":461.01545,"twenty":-53.191367,"median":27.323117,"eighty":43.655773,"marketCap":14974703854},{"date":"2024-11-22","current":417.482022,"twenty":-53.191367,"median":27.323117,"eighty":43.655773,"marketCap":13560651027},{"date":"2024-11-29","current":442.392158,"twenty":-53.191367,"median":27.323117,"eighty":43.655773,"marketCap":14369782072},{"date":"2024-12-06","current":444.349383,"twenty":-53.191367,"median":27.323117,"eighty":43.655773,"marketCap":14433356655},{"date":"2024-12-13","current":420.091655,"twenty":-53.191367,"median":27.323117,"eighty":43.655773,"marketCap":13645417136},{"date":"2024-12-20","current":397.731842,"twenty":-53.191367,"median":27.323117,"eighty":43.655773,"marketCap":12919125697},{"date":"2024-12-27","current":412.559304,"twenty":-53.191367,"median":27.323117,"eighty":43.655773,"marketCap":13400751320},{"date":"2025-01-03","current":412.381375,"twenty":-53.191367,"median":27.323117,"eighty":43.655773,"marketCap":13394971812},{"date":"2025-01-10","current":433.73292,"twenty":-53.207078,"median":27.180562,"eighty":43.823852,"marketCap":14088512709},{"date":"2025-01-17","current":429.81847,"twenty":-53.207078,"median":27.180562,"eighty":44.119588,"marketCap":13961363545},{"date":"2025-01-24","current":430.174329,"twenty":-53.207078,"median":27.180562,"eighty":44.284649,"marketCap":13972922559},{"date":"2025-01-31","current":437.52875,"twenty":-53.207078,"median":27.180562,"eighty":44.759202,"marketCap":14211808868},{"date":"2025-02-07","current":444.527312,"twenty":-53.207078,"median":27.180562,"eighty":45.130091,"marketCap":14439136162},{"date":"2025-02-14","current":415.411306,"twenty":-53.207078,"median":27.180562,"eighty":45.522611,"marketCap":13548639743},{"date":"2025-02-21","current":423.540337,"twenty":-53.207078,"median":27.180562,"eighty":45.966163,"marketCap":13813768103},{"date":"2025-02-28","current":434.220817,"twenty":-53.207078,"median":27.180562,"eighty":46.516696,"marketCap":14162111933},{"date":"2025-03-07","current":415.885994,"twenty":-53.209696,"median":27.168166,"eighty":47.237523,"marketCap":13564121691},{"date":"2025-03-14","current":401.764027,"twenty":-53.209696,"median":27.168166,"eighty":47.318409,"marketCap":13103533738},{"date":"2025-03-21","current":359.457462,"twenty":-53.209696,"median":27.168166,"eighty":47.54487,"marketCap":11723705123},{"date":"2025-03-28","current":360.050822,"twenty":-53.209696,"median":27.168166,"eighty":47.729411,"marketCap":11743057558},{"date":"2025-04-04","current":370.612629,"twenty":-53.209696,"median":27.168166,"eighty":48.105099,"marketCap":12087530901},{"date":"2025-04-11","current":327.356688,"twenty":-53.207078,"median":27.180562,"eighty":48.204584,"marketCap":10676738389},{"date":"2025-04-17","current":342.546703,"twenty":-53.207078,"median":27.180562,"eighty":48.30276,"marketCap":11172160725},{"date":"2025-04-25","current":349.904367,"twenty":-53.209696,"median":27.168166,"eighty":48.304069,"marketCap":11412130919},{"date":"2025-05-02","current":564.51072,"twenty":-53.209696,"median":27.168166,"eighty":48.393956,"marketCap":12007143006},{"date":"2025-05-09","current":543.579321,"twenty":-52.564683,"median":27.496923,"eighty":48.460691,"marketCap":11561932157},{"date":"2025-05-16","current":571.154163,"twenty":15.632391,"median":27.625789,"eighty":48.737881,"marketCap":12148449057},{"date":"2025-05-23","current":587.080228,"twenty":15.726225,"median":27.883789,"eighty":49.007354,"marketCap":12487196442},{"date":"2025-05-30","current":601.004158,"twenty":15.826258,"median":28.029696,"eighty":49.252879,"marketCap":12783358441},{"date":"2025-06-06","current":611.924888,"twenty":15.885314,"median":28.339221,"eighty":49.434802,"marketCap":13015642362},{"date":"2025-06-13","current":629.944092,"twenty":15.934986,"median":28.478966,"eighty":49.660105,"marketCap":13398910831},{"date":"2025-06-20","current":621.298514,"twenty":15.990815,"median":28.671445,"eighty":49.822312,"marketCap":13215019394},{"date":"2025-06-27","current":644.414059,"twenty":16.096118,"median":28.856014,"eighty":50.382952,"marketCap":13706687026},{"date":"2025-07-03","current":622.936624,"twenty":16.116941,"median":28.993122,"eighty":50.591002,"marketCap":13249861982},{"date":"2025-07-11","current":640.136773,"twenty":16.200713,"median":29.581278,"eighty":51.047771,"marketCap":13615709157},{"date":"2025-07-18","current":627.395921,"twenty":16.252966,"median":30.035802,"eighty":51.822721,"marketCap":13344711249},{"date":"2025-07-25","current":641.501864,"twenty":16.33326,"median":30.242404,"eighty":52.761862,"marketCap":13644744647},{"date":"2025-08-01","current":16.792668,"twenty":16.378635,"median":30.24819,"eighty":52.992543,"marketCap":14624230499},{"date":"2025-08-08","current":17.534873,"twenty":16.546711,"median":30.24819,"eighty":52.992543,"marketCap":15270594539},{"date":"2025-08-15","current":19.319752,"twenty":16.607924,"median":30.24819,"eighty":52.992543,"marketCap":16824992653},{"date":"2025-08-22","current":19.402718,"twenty":16.798469,"median":30.24819,"eighty":52.992543,"marketCap":16897244826},{"date":"2025-08-29","current":18.768144,"twenty":16.870655,"median":30.24819,"eighty":52.992543,"marketCap":16344613336},{"date":"2025-09-05","current":19.158306,"twenty":16.99751,"median":30.268023,"eighty":53.052464,"marketCap":16684393828},{"date":"2025-09-12","current":19.321995,"twenty":17.085907,"median":30.24819,"eighty":52.992543,"marketCap":16826945414},{"date":"2025-09-19","current":19.283875,"twenty":17.161262,"median":30.24819,"eighty":52.992543,"marketCap":16793748470},{"date":"2025-09-26","current":18.310712,"twenty":17.193493,"median":30.24819,"eighty":52.992543,"marketCap":15946250000},{"date":"2025-10-03","current":19.34666,"twenty":17.274387,"median":30.24819,"eighty":52.992543,"marketCap":16848425790},{"date":"2025-10-10","current":19.003586,"twenty":17.291711,"median":30.24819,"eighty":52.992543,"marketCap":16549653288},{"date":"2025-10-17","current":19.577618,"twenty":17.328736,"median":30.24819,"eighty":52.992543,"marketCap":17049560219},{"date":"2025-10-24","current":20.02608,"twenty":17.356711,"median":30.24819,"eighty":52.992543,"marketCap":17440112509},{"date":"2025-10-31","current":15.211911,"twenty":17.362586,"median":30.24819,"eighty":52.992543,"marketCap":18080618265},{"date":"2025-11-07","current":17.376278,"twenty":17.372241,"median":30.24819,"eighty":52.992543,"marketCap":20653148355},{"date":"2025-11-14","current":17.410964,"twenty":17.400499,"median":30.24819,"eighty":52.992543,"marketCap":20694376123},{"date":"2025-11-21","current":16.80808,"twenty":17.400499,"median":30.24819,"eighty":52.992543,"marketCap":19977798257},{"date":"2025-11-28","current":17.254049,"twenty":17.411313,"median":30.24819,"eighty":52.992543,"marketCap":20507869555},{"date":"2025-12-05","current":16.593354,"twenty":17.411313,"median":30.24819,"eighty":52.992543,"marketCap":19722578743},{"date":"2025-12-12","current":15.873197,"twenty":17.411313,"median":30.24819,"eighty":52.992543,"marketCap":18866611758},{"date":"2025-12-19","current":16.073057,"twenty":17.411313,"median":30.24819,"eighty":52.992543,"marketCap":19104162228},{"date":"2025-12-26","current":16.590051,"twenty":17.411313,"median":30.24819,"eighty":52.992543,"marketCap":19718652289},{"date":"2026-01-02","current":16.314211,"twenty":17.411313,"median":30.24819,"eighty":52.992543,"marketCap":19390793375},{"date":"2026-01-09","current":17.495203,"twenty":17.426189,"median":30.24819,"eighty":52.992543,"marketCap":20794500701},{"date":"2026-01-16","current":17.382885,"twenty":17.442549,"median":30.24819,"eighty":52.992543,"marketCap":20661001263},{"date":"2026-01-23","current":17.353153,"twenty":17.454595,"median":30.24819,"eighty":52.992543,"marketCap":20625663177},{"date":"2026-01-30","current":16.695762,"twenty":17.454595,"median":30.24819,"eighty":52.992543,"marketCap":19844298819},{"date":"2026-02-06","current":16.973254,"twenty":17.454595,"median":30.24819,"eighty":52.992543,"marketCap":20174120960},{"date":"2026-02-13","current":15.583655,"twenty":17.493061,"median":30.24819,"eighty":52.992543,"marketCap":20050709464},{"date":"2026-02-20","current":15.735238,"twenty":17.493061,"median":30.24819,"eighty":52.992543,"marketCap":20245743660},{"date":"2026-02-27","current":15.481568,"twenty":17.493061,"median":30.24819,"eighty":52.992543,"marketCap":19919359903},{"date":"2026-03-06","current":15.054661,"twenty":17.493061,"median":30.24819,"eighty":52.992543,"marketCap":19370079922},{"date":"2026-03-13","current":14.234876,"twenty":17.493061,"median":30.24819,"eighty":52.992543,"marketCap":18315303146},{"date":"2026-03-20","current":14.377178,"twenty":17.493061,"median":30.24819,"eighty":52.992543,"marketCap":18498396473},{"date":"2026-03-27","current":14.270452,"twenty":17.493061,"median":30.24819,"eighty":52.992543,"marketCap":18361076478},{"date":"2026-04-02","current":14.585992,"twenty":17.493061,"median":30.24819,"eighty":52.992543,"marketCap":18767066029},{"date":"2026-04-10","current":14.997431,"twenty":17.493061,"median":30.24819,"eighty":52.992543,"marketCap":19296444562},{"date":"2026-04-17","current":14.743762,"twenty":17.493061,"median":30.24819,"eighty":52.992543,"marketCap":18970060805},{"date":"2026-04-24","current":14.766963,"twenty":17.493061,"median":30.24819,"eighty":52.992543,"marketCap":18999912978},{"date":"2026-05-01","current":13.293443,"twenty":17.493061,"median":30.24819,"eighty":52.992543,"marketCap":19033245906},{"date":"2026-05-08","current":13.642279,"twenty":17.433127,"median":30.118443,"eighty":52.992543,"marketCap":19532701294},{"date":"2026-05-15","current":13.622744,"twenty":17.411313,"median":29.746559,"eighty":52.992543,"marketCap":19504731792},{"date":"2026-05-22","current":13.592047,"twenty":17.387328,"median":29.09859,"eighty":52.992543,"marketCap":19460779718},{"date":"2026-05-29","current":13.604605,"twenty":17.36462,"median":28.916658,"eighty":53.052464,"marketCap":19478760112},{"date":"2026-06-05","current":14.126463,"twenty":17.348937,"median":28.776913,"eighty":52.992543,"marketCap":20225945372},{"date":"2026-06-12","current":15.045995,"twenty":17.325325,"median":28.50797,"eighty":52.992543,"marketCap":21542509773},{"date":"2026-06-18","current":13.812511,"twenty":17.289424,"median":28.436682,"eighty":52.992543,"marketCap":19776435523},{"date":"2026-06-26","current":15.004135,"twenty":17.272525,"median":28.112465,"eighty":53.052464,"marketCap":21482575127},{"date":"2026-07-02","current":15.880411,"twenty":17.240692,"median":27.997224,"eighty":53.052464,"marketCap":22737207060},{"date":"2026-07-10","current":16.537618,"twenty":17.19048,"median":27.743327,"eighty":53.052464,"marketCap":23678181010},{"date":"2026-07-17","current":16.276689,"twenty":17.163644,"median":27.552445,"eighty":53.052464,"marketCap":23304588380},{"date":"2026-07-24","current":16.28227,"twenty":17.105678,"median":27.323117,"eighty":53.052464,"marketCap":23312579666},{"date":"2026-07-31","current":15.46146,"twenty":17.048056,"median":27.019412,"eighty":53.112386,"marketCap":24929795780},{"date":"2026-08-07","current":14.881923,"twenty":16.977387,"median":26.862395,"eighty":53.112386,"marketCap":23995359171},{"date":"2026-08-14","current":15.150949,"twenty":16.947387,"median":26.172344,"eighty":53.112386,"marketCap":24429132347},{"date":"2026-08-21","current":15.993227,"twenty":16.887518,"median":22.74195,"eighty":53.112386,"marketCap":25787207246}],"updateTime":1787645324576},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"INCY\",pageSize:20,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1144835206","title":"因塞特醫療：關鍵Frontmind試驗顯示Tafasitamab聯合療法顯著延長無進展生存期","url":"https://stock-news.laohu8.com/highlight/detail?id=1144835206","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1144835206?lang=zh_tw&edition=fundamental","pubTime":"2026-05-30 20:08","pubTimestamp":1780142897,"startTime":"0","endTime":"0","summary":"因塞特医疗宣布，其关键的Frontmind临床试验数据表明，Tafasitamab（商品名Monjuvi®/Minjuvi®）联合治疗方案能够显著延长患者的无进展生存期。这一积极结果凸显了该疗法在相关治疗领域的潜在价值。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","INCY","BK4532","BK4139","BK4588","BK4550"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639760958","title":"Incyte的血液癌症聯合用藥方案可降低疾病進展風險，但副作用發生率較高","url":"https://stock-news.laohu8.com/highlight/detail?id=2639760958","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639760958?lang=zh_tw&edition=fundamental","pubTime":"2026-05-30 20:00","pubTimestamp":1780142435,"startTime":"0","endTime":"0","summary":"Incyte的血液癌症联合用药方案可降低疾病进展风险，但副作用发生率较高Monjuvi联合疗法在DLBCL临床试验中降低了疾病进展风险Monjuvi联合疗法严重不良事件和停药率较高，但总体死亡率较低Incyte计划申请扩大美国批准范围，用于一线治疗Christy Santhosh. 路透5月30日 - Incyte公司的 INCY.O Monjuvi 作为多药方案的一部分，该方案包含针对侵袭性非霍奇金淋巴瘤的标准化疗方案，与仅使用标准化疗相比，可将疾病进展、复发或死亡的风险降低25%，但因副作用导致的研究退出率较高。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260530:nL4S427034:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2242652126.USD","LU1670710661.SGD","LU1983299246.USD","LU1323610961.USD","IE0009355771.USD","LU1074936037.SGD","LU0306807586.USD","BK4007","LU1868836591.USD","LU0456855351.SGD","BK4588","LU0267386448.USD","BK4559","LU0882574055.USD","LU1291159041.SGD","LU2242646821.SGD","LU0868494617.USD","LU1868836757.USD","LU0114720955.EUR","LU1093756325.SGD","BK4534","LU1670710588.SGD","LU1868837136.USD","LU2133065610.SGD","LU0321505439.SGD","LU0321505868.SGD","BK4581","LU1093756168.USD","LU1868837300.USD","LU1718418525.SGD","LU0237698245.USD","LU0061475181.USD","LU0225284248.USD","LU1032466523.USD","IE00BJT1NW94.SGD","LU1868836914.USD","LU1571399168.USD","IE00BSNM7G36.USD","IE00BFXG1179.USD","INCY","LU1261432733.SGD","LU2360032135.SGD","LU2125154935.USD","LU0096364046.USD","IE00B2B36J28.USD","BK4139","LU1585245621.USD","BMY","LU0225771236.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636823676","title":"數據簡報-製藥行業加大力度佈局人工智能，寄望於大幅削減成本並縮短研發周期","url":"https://stock-news.laohu8.com/highlight/detail?id=2636823676","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636823676?lang=zh_tw&edition=fundamental","pubTime":"2026-05-20 22:14","pubTimestamp":1779286481,"startTime":"0","endTime":"0","summary":"数据简报-制药行业加大力度布局人工智能，寄望于大幅削减成本并缩短研发周期新增4月后公布的合作伙伴关系和交易。路透5月20日 - 制药公司正越来越多地借助人工智能来加速研发进程，押注于 新型建模工具和自动化实验室，以提升整个 研发管线的效率 。行业预测显示，利用机器学习优化靶点发现、分子设计及简化临床试验规划，有望在未来三到五年内将早期研发周期和成本减半。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260520:nL4T41X1CT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNAM","2NVD.UK","NVDU","BMY","NVDO","00179","MSFL","NVDQ","TMO","AMZY","MSFT","NVDY","MSFU","NVDW","NVDA","AMZW","MSFX","LH","NVDG","NVDB","NVIW.SI","USAW.SI","PFE","MSFO","GGLS","NVDX","MSFD","AMZZ","AZYY","MSFY","SNVD.UK","MSFW","AMZD","AZN.UK","GGLL","KVUE","DIPS","GOOGL","KD","3NVD.UK","ANV","MRK","NVDS","INCY","NVDL","AMZU","IQV","NVDD","AMZP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636816228","title":"美國研究綜述-CAVA集團、Eagle Materials、Vertiv控股","url":"https://stock-news.laohu8.com/highlight/detail?id=2636816228","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636816228?lang=zh_tw&edition=fundamental","pubTime":"2026-05-20 15:08","pubTimestamp":1779260900,"startTime":"0","endTime":"0","summary":"美国研究综述-CAVA集团、Eagle Materials、Vertiv控股路透5月20日 - 周三，华尔街的证券分析师们修订了多家在美国上市公司的评级和目标股价，其中包括CAVA集团、Eagle Materials和Vertiv控股。股票条目按字母顺序排列。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260520:nL4T41X0MS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VRTX","BK4585","DRUG","UTHR","BK4548","LU0130103400.USD","BMRN","IE0002270589.USD","MRNX","LU0868494708.USD","MRNY","RLAY","IE00B7SZLL34.SGD","VRT","ALNY","LU0943347566.SGD","LU0878866978.SGD","BRO","IE00BN0W2V16.EUR","CAVA","JAZZ","UHS","LU0098860793.USD","BK4139","LU0417517546.SGD","LU1989772840.SGD","LU2108987350.USD","IONS","LU2249611893.SGD","LU2720916845.USD","HALO","LU0882574055.USD","IE00BKPKM429.USD","EXP","CHRW","LU2290526834.HKD","HD","VRTL","LU2462157665.USD","IE00B1XK9C88.USD","BK4534","MIRM","INCY","LU1035775433.USD","MRNA","IE00BMPRXR70.SGD","LU2065731478.USD","THC","LU2543165471.USD","INSM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636162238","title":"美國研究綜述-CAVA集團、Eagle Materials、Vertiv控股","url":"https://stock-news.laohu8.com/highlight/detail?id=2636162238","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636162238?lang=zh_tw&edition=fundamental","pubTime":"2026-05-20 15:08","pubTimestamp":1779260900,"startTime":"0","endTime":"0","summary":"美国研究综述-CAVA集团、Eagle Materials、Vertiv控股路透5月20日 - 周三，华尔街的证券分析师们修订了多家在美国上市公司的评级和目标股价，其中包括CAVA集团、Eagle Materials和Vertiv控股。股票条目按字母顺序排列。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260520:nL4S41X0MS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","MRNY","THC","LU0942090050.USD","UTHR","LU1303367103.USD","VRT","IE00B19Z9P08.USD","JAZZ","INSM","UHS","IE0002270589.USD","BK4083","IE00B1XK9C88.USD","LU1551013342.USD","HD","IE00BZ1G4Q59.USD","VRTL","MRNA","MIRM","LU2125909916.SGD","DRUG","HALO","LU0061475181.USD","SG9999001440.SGD","LU1929549753.HKD","RLAY","BMRN","IE00B7SZLL34.SGD","VRTX","BK4568","BRO","LU1035775433.USD","EXP","LU0868494617.USD","ALNY","MRNX","BK4209","LU0238689110.USD","IONS","BK4501","LU2362541513.USD","CAVA","CHRW","LU0079474960.USD","LU2456880835.USD","INCY","LU0823414551.USD","LU0878866978.SGD","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165248541","title":"因塞特醫療與愛迪生科學宣佈戰略合作，將啓用Kosmos AI平台賦能研發","url":"https://stock-news.laohu8.com/highlight/detail?id=1165248541","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165248541?lang=zh_tw&edition=fundamental","pubTime":"2026-05-19 20:08","pubTimestamp":1779192523,"startTime":"0","endTime":"0","summary":"因塞特医疗与爱迪生科学公司已共同宣布达成一项战略合作。双方将启用Kosmos人工智能平台，以加速并深化其在生物医药领域的研究与开发工作。\n此次合作旨在整合前沿的人工智能技术，探索新的科学发现路径。通过利用Kosmos平台强大的数据处理与分析能力，两家公司期望能够更高效地识别潜在的治疗靶点，优化候选药物分子设计，并最终推动创新疗法的开发进程。\n战略联盟的建立，标志着双方在利用数字化工具驱动研发创新方面迈出了关键一步。这一举措不仅有望缩短药物研发周期，也可能为应对复杂疾病带来新的解决方案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INCY","BK4585","BK4532","BK4550","BK4588","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169983668","title":"因塞特醫療宣佈超過20篇摘要獲選於2026年歐洲血液學協會大會展示","url":"https://stock-news.laohu8.com/highlight/detail?id=1169983668","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169983668?lang=zh_tw&edition=fundamental","pubTime":"2026-05-12 21:31","pubTimestamp":1778592686,"startTime":"0","endTime":"0","summary":"因塞特医疗宣布，其超过20篇研究摘要已获选在即将举行的2026年欧洲血液学协会大会上进行展示。这一成果突显了公司在血液学领域的持续研究投入与科学贡献。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","BK4588","INCY","BK4585","BK4550","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194577649","title":"因塞特醫療Opzelura耐受性良好：24周內僅1.7%用藥部位反應且無新增安全信號","url":"https://stock-news.laohu8.com/highlight/detail?id=1194577649","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194577649?lang=zh_tw&edition=fundamental","pubTime":"2026-05-07 20:51","pubTimestamp":1778158306,"startTime":"0","endTime":"0","summary":"因塞特医疗旗下药物Opzelura在长达24周的临床观察中展现出卓越的安全性表现。数据显示，该药物引发的用药部位反应率仅为1.7%，且未出现新的安全性风险信号。\n研究人员指出，这一结果进一步验证了Opzelura在长期用药场景下的可靠性与安全性。极低的局部反应发生率结合零新增安全信号的特性，为慢性疾病患者提供了重要的临床用药依据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INCY","BK4585","BK4588","BK4550","BK4532","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108490356","title":"因塞特公布Opzelura乳膏治療中重度特應性皮炎三期試驗24周長期數據","url":"https://stock-news.laohu8.com/highlight/detail?id=1108490356","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108490356?lang=zh_tw&edition=fundamental","pubTime":"2026-05-07 20:51","pubTimestamp":1778158277,"startTime":"0","endTime":"0","summary":"生物制药公司因塞特医疗近日公布了其研发的Opzelura®（芦可替尼）乳膏在三期临床试验TRUE-AD4中取得的24周长期疗效数据。该研究针对中重度特应性皮炎成人患者展开系统性评估。\n试验结果显示，持续使用Opzelura乳膏治疗24周的患者群体呈现出显著且持久的临床症状改善。数据分析表明，该局部治疗药物在延长治疗周期下仍保持稳定的安全性和耐受性特征。\n此次公布的长期数据为芦可替尼乳膏在慢性皮肤病治疗领域的应用提供了更充分的循证医学依据。研究人员指出，这些发现将有助于优化中重度特应性皮炎患者的长期治疗策略。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","INCY","BK4532","BK4139","BK4550","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108170491","title":"因塞特醫療：蘆可替尼乳膏歐盟II類變更申請獲數據支持，反饋預期2026年上半年","url":"https://stock-news.laohu8.com/highlight/detail?id=1108170491","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108170491?lang=zh_tw&edition=fundamental","pubTime":"2026-05-07 20:51","pubTimestamp":1778158276,"startTime":"0","endTime":"0","summary":"因塞特医疗（Incyte）宣布，其芦可替尼乳膏在欧盟的II类变更申请已获得最新数据支持。公司预计将于2026年上半年获得监管机构的反馈意见。\n此次申报进展标志着该药物在欧盟市场拓展的重要里程碑。临床数据将为申请提供关键依据，助力乳膏剂型在欧盟地区的审批进程。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INCY","BK4588","BK4139","BK4550","BK4532","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157281920","title":"因塞特醫療宣佈FDA批准Jakafi XR™緩釋片用於治療骨髓纖維化、真性紅細胞增多症及移植物抗宿主病","url":"https://stock-news.laohu8.com/highlight/detail?id=1157281920","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157281920?lang=zh_tw&edition=fundamental","pubTime":"2026-05-02 05:29","pubTimestamp":1777670981,"startTime":"0","endTime":"0","summary":"生物制药企业因塞特医疗近日宣布，其研发的Jakafi XR™（鲁索替尼）缓释片剂已获得美国食品药品监督管理局（FDA）批准，将用于治疗骨髓纤维化、真性红细胞增多症以及移植物抗宿主病。此次获批标志着该药物在剂型上的重要升级，将为相关疾病患者提供更为便捷的每日一次服药选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INCY","BK4588","BK4139","BK4550","BK4532","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630588069","title":"因賽特受抗癌藥需求強勁推動，第一季度業績超預期","url":"https://stock-news.laohu8.com/highlight/detail?id=2630588069","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630588069?lang=zh_tw&edition=fundamental","pubTime":"2026-04-28 22:00","pubTimestamp":1777384852,"startTime":"0","endTime":"0","summary":"因赛特受抗癌药需求强劲推动，第一季度业绩超预期路透4月28日 - 制药公司Incyte INCY.O 周二公布的季度利润和营收均超出分析师预期，这在一定程度上得益于其抗癌药物的强劲需求。季度总营收为12.7亿美元，同样高于12.1亿美元的预期。得益于所有获批适应症需求增强，Jakafi净销售额增长7%至7.578亿美元，超出预期。Incyte重申了全年销售额47.7亿至49.4亿美元的预测。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260428:nL4S41B1X8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BSNM7G36.USD","BK4566","IE0002270589.USD","LU1261432733.SGD","INCY","LU0648001328.SGD","IE00B2B36J28.USD","LU0128525929.USD","LU2242646821.SGD","LU0306806265.USD","LU2133065610.SGD","LU0477156953.USD","LU1868836914.USD","IE00B7SZLL34.SGD","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","LU0006061336.USD","LU1267930813.SGD","LU2360032135.SGD","LU1430594728.SGD","ZBH","LU0432979614.USD","BMY","LU0889566641.SGD","LU1670711040.USD","LU0211327993.USD","LU0321505868.SGD","LU1291159041.SGD","LU2125154935.USD","BK4534","BK4504","IE0009355771.USD","LU0792757196.USD","LU0130102774.USD","IE00B19Z3B42.SGD","BK4588","LU1093756325.SGD","LU2125154778.USD","LU0310799852.SGD","LU1571399168.USD","LU2242652126.USD","BK4581","LU1267930573.SGD","LU1718418525.SGD","LU0306807586.USD","BK4550","LU1868837300.USD","LU1983299246.USD","LU0708994859.HKD","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152839112","title":"因塞特醫療Jakafi XR新藥即將迎來關鍵節點 美國監管決定與中期商業上市計劃浮出水面","url":"https://stock-news.laohu8.com/highlight/detail?id=1152839112","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152839112?lang=zh_tw&edition=fundamental","pubTime":"2026-04-28 19:07","pubTimestamp":1777374434,"startTime":"0","endTime":"0","summary":"因塞特医疗旗下备受关注的Jakafi XR（鲁索利替尼）缓释片剂迎来重要进展。该公司预期将在2026年中期获得美国监管机构的审评结果，并有望同期启动该药物的商业化上市进程。\n这一时间节点的明确为血液疾病治疗领域注入新的期待。若获批，Jakafi XR将成为因塞特医疗产品管线中的重要延伸，为患者提供更便捷的用药选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INCY","BK4532","BK4585","BK4139","BK4550","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138548835","title":"財報前瞻｜因塞特醫療本季度營收預計按年增22.99%，機構多持積極態度","url":"https://stock-news.laohu8.com/highlight/detail?id=1138548835","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138548835?lang=zh_tw&edition=fundamental","pubTime":"2026-04-20 23:56","pubTimestamp":1776700611,"startTime":"0","endTime":"0","summary":"因塞特医疗将于2026年04月27日发布最新季度财报，市场普遍预期收入与盈利维持同比增长，费用端和产品结构变化将影响利润弹性。上季度公司实现营收15.07亿美元，同比增长27.84%；毛利率51.38%；归属于母公司股东的净利润为2.99亿美元，净利率19.86%；调整后每股收益为1.80美元，同比增长25.87%。多家机构聚焦于本季度收入同比增22.99%、调整后每股收益同比增37.37%的共识路径，并强调产品组合驱动的毛利率稳定与EBIT高增可持续性。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻｜因塞特医疗本季度营收预计同比增22.99%，机构多持积极态度","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INCY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627414909","title":"背景資料-醫藥行業加倍重視人工智能，希望能降低成本、縮短時間","url":"https://stock-news.laohu8.com/highlight/detail?id=2627414909","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627414909?lang=zh_tw&edition=fundamental","pubTime":"2026-04-14 17:47","pubTimestamp":1776160021,"startTime":"0","endTime":"0","summary":"背景资料-医药行业加倍重视人工智能，希望能降低成本、缩短时间更改日期线，增加诺和诺德与 OpenAI 的交易。路透4月14日 - 制药公司正越来越多地利用人工智能来加快研发速度，并寄希望于新的建模工具和自动化实验室来提高整个研发流程的效率。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260414:nL4S40X0T3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1803068979.SGD","LU1989773731.SGD","NVDA","NVDQ","NVDY","AZN.UK","LU1037948541.HKD","NVII","MSFL","2NVD.UK","NVDD","NVDO","NVDS","MSFX","NVD","MSFY","NVDX","MSFD","NVDL","SNVD.UK","DIPS","BK4592","KD","TMO","LU1548497426.USD","NVIW.SI","LU2430703251.USD","MSFT","PFE","NVD3.UK","NVDW","BK4599","LU2322448957.HKD","NVDU","KVUE","MSFU","IQV","INCY","03165","3NVD.UK","NVD2.UK","MSFO","NVDG","MSFW","NVDS.UK","NVDB","RNAM","LU2362541513.USD","ANV","MRK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184093165","title":"Adagene與Incyte達成臨床合作，評估Muzastotug (Adg126)聯合Incyte的TgfßR2xPD-1雙特異性抗體(Inca33890)用於微衞星穩定結直腸癌(MSS CRC)患者","url":"https://stock-news.laohu8.com/highlight/detail?id=1184093165","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184093165?lang=zh_tw&edition=fundamental","pubTime":"2026-04-02 19:02","pubTimestamp":1775127720,"startTime":"0","endTime":"0","summary":"Adagene宣布与Incyte达成临床合作，将共同评估Muzastotug (Adg126)与Incyte的TgfßR2xPD-1双特异性抗体(Inca33890)联合疗法在微卫星稳定结直肠癌(MSS CRC)患者中的疗效。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INCY","BK4532","BK4588","BK4550","BK4585","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623584462","title":"人工智能引領的合同研究公司拋售可能是對顛覆性風險的誤判","url":"https://stock-news.laohu8.com/highlight/detail?id=2623584462","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623584462?lang=zh_tw&edition=fundamental","pubTime":"2026-03-31 21:05","pubTimestamp":1774962316,"startTime":"0","endTime":"0","summary":"人工智能引领的合同研究公司抛售可能是对颠覆性风险的误判Kamal Choudhury/Siddhi Mahatole. 路透3月31日 - 由于担心人工智能的进步会让制药商将临床试验工作收归内部，合同研究组织的股价出现暴跌，但业内专家表示，这种暴跌高估了人工智能技术在多大程度上可以取代该行业的核心能力。就目前而言，分析师认为没有证据表明制药公司会因为人工智能而削减对CRO的支出，并称这种抛售是 \"恐慌而不是真正的威胁\"。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nL4S40J19P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IQV","BK4599","BK4530","LU1066053197.SGD","SGXZ57979304.SGD","IE000M9KFDE8.USD","BK4121","LU0882574055.USD","IE0002270589.USD","LU0321505439.SGD","SG9999002224.SGD","LU1791710582.SGD","LU0058720904.USD","LU0234572021.USD","SG9999002232.USD","LU0225284248.USD","BK4550","LU0985481810.HKD","LU0130102774.USD","LU1066051498.USD","BK4533","LU1057294990.SGD","SG9999003800.SGD","INCY","BK4592","LU2065169927.USD","LU0128526141.USD","LU0648000940.SGD","LU1815336091.USD","BK4581","IE00BBT3K403.USD","BK4007","LU2065170008.USD","BK4534","SG9999011175.SGD","LU1989764748.USD","BK4588","BK4139","LU0198837287.USD","LU1791710400.SGD","LU0306807586.USD","LU0477156797.USD","BK4568","IE00B19Z3B42.SGD","LU0170899867.USD","LU0029874061.USD","LU1261432733.SGD","LU0225771236.USD","LU0321505868.SGD","LU0390134368.USD","LU0456855351.SGD","LU1883839398.USD","SG9999001176.SGD","SG9999013999.USD","LU0868494617.USD","LU0757428866.USD","LU1894683348.USD","LU0648001328.SGD","SG9999001176.USD","IE00BLSP4452.SGD","MEDP","LU0289739699.SGD","BK4082","BK4585","LU0130103400.USD","LU1989764664.SGD","LU0130517989.USD","LU0980610538.SGD","IE00BFMHRM44.USD","LU1201861249.SGD","LU0122379950.USD","LU0306806265.USD","LU1894683264.USD","BK4532","IE00BLSP4239.USD","LU0477156953.USD","LU0528227936.USD","LU2065171402.SGD","IE00B19Z3581.USD","LU1023059063.AUD","LU2065171311.SGD","LU0130518102.USD","LU1201861165.SGD","CRL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149961708","title":"因塞特醫療在2026年美國皮膚病學會年會公布Povorcitinib治療化膿性汗腺炎54周積極最新數據","url":"https://stock-news.laohu8.com/highlight/detail?id=1149961708","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1149961708?lang=zh_tw&edition=fundamental","pubTime":"2026-03-29 03:01","pubTimestamp":1774724474,"startTime":"0","endTime":"0","summary":"因塞特医疗（Incyte）于2026年美国皮肤病学会（AAD）年会上，公布了其研发药物Povorcitinib用于治疗化脓性汗腺炎（Hidradenitis Suppurativa）的54周最新积极数据。这些迟来但重要的突破性研究结果，进一步验证了该疗法在长期应用中的有效性与安全性，为患者带来了新的希望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INCY","BK4550","BK4532","BK4585","BK4588","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623833888","title":"Incyte 的皮膚病藥物在後期試驗中顯示出長期症狀緩解效果","url":"https://stock-news.laohu8.com/highlight/detail?id=2623833888","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623833888?lang=zh_tw&edition=fundamental","pubTime":"2026-03-29 03:00","pubTimestamp":1774724440,"startTime":"0","endTime":"0","summary":"Incyte 的皮肤病药物在后期试验中显示出长期症状缓解效果路透3月28日 - Incyte公司INCY.O周六表示，其实验性皮肤病药物在两项后期试验中显示症状长期减轻。研究还显示，多达57%的患者症状明显减轻，多达29%的患者主要皮损完全清除。该病的治疗方法有限，主要是注射药物。Incyte公司说，最常见的副作用是痤疮、鼻咽炎和上呼吸道感染。Incyte公司表示，美国食品和药物管理局和欧洲药品管理局目前正在审查寻求批准波伏西替尼的申请。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260328:nL4S40G03P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2237443465.HKD","IE00BJJMRZ35.SGD","LU0203347892.USD","LU2237443895.HKD","LU1093756325.SGD","LU2133065610.SGD","INCY","IE00B19Z3B42.SGD","IE00BSNM7G36.USD","LU2129689431.USD","LU2237443382.USD","LU1244550577.SGD","IE00BVYPNW00.USD","ABBV","LU0943347566.SGD","LU0170899867.USD","LU0320765646.SGD","LU1934455194.USD","SG9999015986.USD","LU0820561909.HKD","LU0256863902.USD","IE0002270589.USD","LU1496350502.SGD","LU0310799852.SGD","LU1162221912.USD","LU2089284900.SGD","LU1037948541.HKD","LU1732800096.USD","LU2089984988.USD","LU2129689514.USD","BK4581","LU0058720904.USD","LU0098860793.USD","LU1291159041.SGD","LU0965509283.SGD","LU1934455277.USD","LU0057025933.USD","LU1551013425.SGD","BK4550","LU1003077747.HKD","LU0029864427.USD","LU0234570918.USD","LU0310800379.SGD","BK4585","LU1267930490.SGD","BK4139","LU0511384066.AUD","BK4559","LU1989772923.USD","IE00BDGV0183.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143702769","title":"因塞特醫療：截至第54周，STOP-HS1與STOP-HS2研究中所有組別均觀察到臨床持久緩解，高達71.4%患者達到HISCR50","url":"https://stock-news.laohu8.com/highlight/detail?id=1143702769","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143702769?lang=zh_tw&edition=fundamental","pubTime":"2026-03-29 03:00","pubTimestamp":1774724430,"startTime":"0","endTime":"0","summary":"在因塞特医疗（Incyte）最新公布的临床研究数据中，STOP-HS1与STOP-HS2两项试验进展引人瞩目。截至第54周观察期，所有治疗组别均展现出具有临床意义的持久治疗反应。尤为突出的是，在特定患者群体中，实现HISCR50（即银屑病面积与严重程度指数改善至少50%）治疗目标的患者比例最高达到71.4%。\n这一突破性数据印证了治疗方案在不同严重程度患者中保持的持续有效性。研究结果显示，随着治疗时间延长，药物疗效呈现稳定维持态势，为中度至重度化脓性汗腺炎患者提供了新的治疗希望。持续54周的跟踪观察进一步验证了治疗方案的长期安全性特征，为后续临床应用奠定了坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","INCY","BK4532","BK4139","BK4550","BK4588"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":3,"totalSize":68,"code":"91000000","status":"200"}]}}